6.01Open6.01Pre Close0 Volume4 Open Interest71.00Strike Price0.00Turnover87.90%IV-4.82%PremiumDec 6, 2024Expiry Date9.91Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9696Delta0.0120Gamma8.09Leverage Ratio-0.0673Theta0.0045Rho7.84Eff Leverage0.0045Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet